Inspire Medical Systems, Inc.

NYSE:INSP Stock Report

Market Cap: US$7.2b

Inspire Medical Systems Past Earnings Performance

Past criteria checks 0/6

Inspire Medical Systems's earnings have been declining at an average annual rate of -3.5%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 47.9% per year.

Key information

-3.5%

Earnings growth rate

2.9%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate47.9%
Return on equity-3.7%
Net Margin-3.4%
Next Earnings Update07 May 2024

Recent past performance updates

Recent updates

Inspire Medical Systems: A Potential Example Of Market Mispricing

Apr 05

Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Mar 27
Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Mar 06
Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Inspire Medical: A Good Night Sleep

Feb 08

Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors

Dec 26
Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors

Inspire Medical Systems: Time To Wake Up

Nov 17

An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued

Nov 13
An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued

Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth

Oct 25

When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?

Sep 05
When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?

Inspire Medical Systems: Excellent Execution And Reset Valuation

Aug 17

Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?

Aug 10
Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?

Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment

Jul 19

Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing

Jul 16
Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing

Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating

Jun 15

Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching

May 06
Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching

Inspire Medical stock rises after guiding revenue above estimates

Jan 09

Inspire Medical nears eight-month high as KeyBanc issues bullish call

Dec 13

Inspire Medical Systems: Sleep Apnea Equipment - Today's Best Stock Buy

Oct 26

Inspire Medical Systems: Sleep Apnea Value Delivery Pocket

Oct 13

Inspire Medical Systems prices 1M of stock offering at $215.00/share

Aug 12

Inspire Medical Systems GAAP EPS of -$0.53 beats by $0.07, revenue of $91.4M beats by $13.34M

Aug 02

Inspire Medical gets FDA nod for full-body MRI compatibility with Inspire therapy

Jul 06

Inspire Medical Systems Priced Low In Past-Year Repeated Range

May 12

Inspire Medical Systems (NYSE:INSP) Has Debt But No Earnings; Should You Worry?

May 01
Inspire Medical Systems (NYSE:INSP) Has Debt But No Earnings; Should You Worry?

Revenue & Expenses Breakdown
Beta

How Inspire Medical Systems makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSE:INSP Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23625-21452117
30 Sep 23570-33423107
30 Jun 23526-4139599
31 Mar 23466-4435982
31 Dec 22408-4532169
30 Sep 22348-5028558
30 Jun 22301-4425246
31 Mar 22262-4322441
31 Dec 21233-4220337
30 Sep 21201-4718234
30 Jun 21175-4716232
31 Mar 21134-5714129
31 Dec 20115-5712826
30 Sep 2096-5911723
30 Jun 2081-5710719
31 Mar 2087-4110016
31 Dec 1982-339013
30 Sep 1972-297811
30 Jun 1964-25699
31 Mar 1957-24628
31 Dec 1851-22547
30 Sep 1844-21487
30 Jun 1838-21426
31 Mar 1833-20376
31 Dec 1729-18326
31 Dec 1616-19237
31 Dec 158-21187

Quality Earnings: INSP is currently unprofitable.

Growing Profit Margin: INSP is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: INSP is unprofitable, and losses have increased over the past 5 years at a rate of 3.5% per year.

Accelerating Growth: Unable to compare INSP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: INSP is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.5%).


Return on Equity

High ROE: INSP has a negative Return on Equity (-3.69%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.